| Dr Kevin M Brady, MD | |
|
500 W Thomas Rd Ste 500, Phoenix, AZ 85013-4220 | |
| (602) 406-4000 | |
| Not Available |
| Full Name | Dr Kevin M Brady |
|---|---|
| Gender | Male |
| Speciality | Cardiac Surgery |
| Experience | 29 Years |
| Location | 500 W Thomas Rd Ste 500, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154315810 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 30436 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St. Joseph's Hospital And Medical Center | Phoenix, AZ | Hospital |
| Chandler Regional Medical Center | Chandler, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sjhmc Physician Services | 4486646197 | 533 |
News Archive
Greater brand–brand competition alone will likely not lower list prices of brand-name drugs in the US, according to a study published July 30 in the open-access journal PLOS Medicine by Ameet Sarpatwari of Brigham and Women's Hospital and Harvard Medical School, and colleagues.
On a sweltering July morning, Rose Wilson struggled to breathe as she sat in her bed, the light from her computer illuminating her face and the oxygen tubes in her nose.
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today the formation of the company's world renowned Scientific Advisory Board (SAB). The SAB was established to provide miRagen with valuable guidance in developing an extensive pipeline of microRNA-based drugs and is comprised of leaders who are internationally recognized experts in their respective fields.
The Universities of Birmingham and Cambridge have launched a new research project aimed at discovering if selective P2X7 receptor blocker drugs can be repurposed to treat patients with secondary brain damage.
Children and adolescents living with HIV have higher rates of risk factors for cardiovascular issues than HIV-negative children and adolescents, according to a study published in the June issue of the Journal of Pediatrics, the Miami Herald reports. In addition, many antiretroviral drugs can increase cardiovascular risk factors, the Herald reports.
› Verified 5 days ago
| Entity Name | Southwest Heart & Lung, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528127305 PECOS PAC ID: 5597655860 Enrollment ID: O20040318001653 |
News Archive
Greater brand–brand competition alone will likely not lower list prices of brand-name drugs in the US, according to a study published July 30 in the open-access journal PLOS Medicine by Ameet Sarpatwari of Brigham and Women's Hospital and Harvard Medical School, and colleagues.
On a sweltering July morning, Rose Wilson struggled to breathe as she sat in her bed, the light from her computer illuminating her face and the oxygen tubes in her nose.
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today the formation of the company's world renowned Scientific Advisory Board (SAB). The SAB was established to provide miRagen with valuable guidance in developing an extensive pipeline of microRNA-based drugs and is comprised of leaders who are internationally recognized experts in their respective fields.
The Universities of Birmingham and Cambridge have launched a new research project aimed at discovering if selective P2X7 receptor blocker drugs can be repurposed to treat patients with secondary brain damage.
Children and adolescents living with HIV have higher rates of risk factors for cardiovascular issues than HIV-negative children and adolescents, according to a study published in the June issue of the Journal of Pediatrics, the Miami Herald reports. In addition, many antiretroviral drugs can increase cardiovascular risk factors, the Herald reports.
› Verified 5 days ago
| Entity Name | Sjhmc Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326098005 PECOS PAC ID: 4486646197 Enrollment ID: O20040401001189 |
News Archive
Greater brand–brand competition alone will likely not lower list prices of brand-name drugs in the US, according to a study published July 30 in the open-access journal PLOS Medicine by Ameet Sarpatwari of Brigham and Women's Hospital and Harvard Medical School, and colleagues.
On a sweltering July morning, Rose Wilson struggled to breathe as she sat in her bed, the light from her computer illuminating her face and the oxygen tubes in her nose.
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today the formation of the company's world renowned Scientific Advisory Board (SAB). The SAB was established to provide miRagen with valuable guidance in developing an extensive pipeline of microRNA-based drugs and is comprised of leaders who are internationally recognized experts in their respective fields.
The Universities of Birmingham and Cambridge have launched a new research project aimed at discovering if selective P2X7 receptor blocker drugs can be repurposed to treat patients with secondary brain damage.
Children and adolescents living with HIV have higher rates of risk factors for cardiovascular issues than HIV-negative children and adolescents, according to a study published in the June issue of the Journal of Pediatrics, the Miami Herald reports. In addition, many antiretroviral drugs can increase cardiovascular risk factors, the Herald reports.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin M Brady, MD 10930 N Tatum Blvd, Ste 103, Phoenix, AZ 85028-6069 Ph: (602) 263-7600 | Dr Kevin M Brady, MD 500 W Thomas Rd Ste 500, Phoenix, AZ 85013-4220 Ph: (602) 406-4000 |
News Archive
Greater brand–brand competition alone will likely not lower list prices of brand-name drugs in the US, according to a study published July 30 in the open-access journal PLOS Medicine by Ameet Sarpatwari of Brigham and Women's Hospital and Harvard Medical School, and colleagues.
On a sweltering July morning, Rose Wilson struggled to breathe as she sat in her bed, the light from her computer illuminating her face and the oxygen tubes in her nose.
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today the formation of the company's world renowned Scientific Advisory Board (SAB). The SAB was established to provide miRagen with valuable guidance in developing an extensive pipeline of microRNA-based drugs and is comprised of leaders who are internationally recognized experts in their respective fields.
The Universities of Birmingham and Cambridge have launched a new research project aimed at discovering if selective P2X7 receptor blocker drugs can be repurposed to treat patients with secondary brain damage.
Children and adolescents living with HIV have higher rates of risk factors for cardiovascular issues than HIV-negative children and adolescents, according to a study published in the June issue of the Journal of Pediatrics, the Miami Herald reports. In addition, many antiretroviral drugs can increase cardiovascular risk factors, the Herald reports.
› Verified 5 days ago
Michael Anthony Smith, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 500 W Thomas Rd Ste 500, Phoenix, AZ 85013 Phone: 602-406-4000 Fax: 602-406-6498 | |
Jeffrey T. Sugimoto, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 350 W Thomas Rd, Phoenix, AZ 85013 Phone: 602-406-3874 Fax: 602-212-4768 | |
Jeremy Torstveit, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 1010 E Mcdowell Rd Ste 300, Phoenix, AZ 85006 Phone: 602-900-6509 | |
Dr. Dawn E Jaroszewski, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 5779 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-301-8000 | |
Dr. Modesto Jose Colon, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 3131 E Clarendon Ave, Suite 102, Phoenix, AZ 85016 Phone: 602-253-9168 Fax: 602-251-3126 | |
Li Zhang, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 3131 E Clarendon Ave Ste 102, Phoenix, AZ 85016 Phone: 602-253-9168 Fax: 602-251-3126 | |
Jenna Navarro, PA Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 3131 E Clarendon Ave Ste 102, Phoenix, AZ 85016 Phone: 602-253-9168 |